INICEA
Acquired by
CLARIANE
INICEA acquired by CLARIANE
Target
INICEA
Acquirer
CLARIANE
Context
INICEA, which reported an EBITDA margin of LOGIN in 2021, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a level LOGIN the average currently observed in the Healthcare & Pharma sector (13.3x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Inicea is a French private psychiatric and addiction care specialist operating a network of 19 establishments at the time of the transaction, focused on mental health and addictology services. The group has developed a distinctive and innovative approach to ambulatory care, notably through the opening of autonomous day care reception centres (centres d'accueil de jour autonomes), positioning it as a pioneer in outpatient mental health pathways in France. Inicea's clinical model emphasises innovative care pathways developed in close collaboration with medical staff and nursing teams, with a particular focus on patients suffering from psychiatric disorders.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with INICEA
REFERENCES
Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).